Cara O'Mahoney, Ian Watt, Sebastian Fiedler, Sean Devenish, Sujata Srikanth, Erica Justice, Tristan Dover, Delphine Dean, Congyue Peng
SARS-CoV-2 has rampantly spread around the globe and continues to cause unprecedented loss through ongoing waves of (re)infection. Increasing our understanding of the protection against infection with SARS-CoV-2 is critical to ending the pandemic. Serological assays have been widely used to assess immune responses, but secretory antibodies, the essential first line of defense, have been studied to only a limited extent. Of particular interest and importance are neutralizing antibodies, which block the binding of the spike protein of SARS-CoV-2 to the human receptor angiotensin-converting enzyme-2 (ACE2) and thus are essential for immune defense...
March 8, 2024: Annals of Biomedical Engineering